报告题目：Mechanism and Treatment of Cancer Associated Muscle Weakness
报告人：Andrew R. Marks, M.D.
Wu Professor and Chairman
Department of Physiology and Cellular Biophysics
Columbia University College of Physicians & Surgeons
时 间：2018 年12 月13 日（星期四）上午9:30-10:30
Andrew R. Marks received his B.D. from the Amherst College and his M.D. from Harvard Medical School, USA. He completed his medical training in internal medicine, molecular genetics and clinical cardiology at the Massachusetts General Hospital (MGH). He is board certified in internal medicine and cardiology. Dr. Marks is now Chair and Professor of Physiology and Cellular Biophysics Department at Columbia University. He is the member of the National Academy of Medicine (2004), American Academy of Arts and Sciences (2005) and the National Academy of Sciences (2005). He was Editor-in-Chief of the Journal of Clinical Investigation. He has received a number of honors including: ASCI, AAP, Doctor of Science Honoris Causa from Amherst College (2009), the ASCI Stanley J. Korsmeyer Award (2010), the Pasarow Foundation Award for Cardiovascular Research (2011), Docteur Honoris causa, de l’Université de Montpellier (2016), Glorney-Raisbeck and award from NY Academy of Medicine (2016). He has solved high resolution structure of the ryanodine receptor/calcium release channel. Dr. Marks developed Rycal drugs, which target leaky ryanodine receptor channels and effectively treat cardiac arrhythmias, heart failure, muscular dystrophy and prevent stress induced cognitive dysfunction and Alzheimer’s disease in pre-clinical studies.